Literature DB >> 10473095

Expression of dominant-negative Ikaros isoforms in T-cell acute lymphoblastic leukemia.

L Sun1, M L Crotty, M Sensel, H Sather, C Navara, J Nachman, P G Steinherz, P S Gaynon, N Seibel, C Mao, A Vassilev, G H Reaman, F M Uckun.   

Abstract

Ikaros, a zinc finger-containing DNA-binding protein, is required for normal lymphocyte development. Germ-line mutant mice that express only non-DNA binding dominant-negative "leukemogenic" Ikaros isoforms lacking critical NH2-terminal zinc fingers develop an aggressive form of T-cell leukemia. We studied Ikaros gene expression in leukemic cells from 18 children with T-cell acute lymphoblastic leukemia (T-ALL). In each of the 18 T-ALL cases as well as JK-E6-1 and MOLT-3 cell lines, we found high-level expression of dominant-negative isoforms of Ikaros with abnormal subcellular compartmentalization patterns. Nuclear extracts from these cells failed to bind to the IKAROS-specific binding sequence in DNA. PCR cloning and sequencing confirmed that JK-E6-1 and MOLT-3 cell lines as well as leukemic cells from 9 of 10 patients with T-ALL expressed dominant-negative Ikaros isoforms Ik-4, Ik-7, and Ik-8 that lack critical NH2-terminal zinc fingers. In 6 of 10 patients, we detected a specific mutation leading to an in-frame deletion of 10 amino acids (delta KSSMPQKFLG) upstream to the transcription activation domain and adjacent to the COOH-terminal zinc fingers of Ik-2, Ik-4, Ik-7, and Ik-8. Thus, children with T-ALL express high levels of dysfunctional dominant-negative Ikaros isoforms.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10473095

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  31 in total

1.  T-ALL can evolve to oncogene independence.

Authors:  Hesham Abdulla; Anh Vo; Benjamin J Shields; Tenae J Davies; Jacob T Jackson; Raed Alserihi; Elizabeth M Viney; Tin Wong; Feng Yan; Nicholas C Wong; Lisa Demoen; David J Curtis; Warren S Alexander; Pieter Van Vlierberghe; Ross A Dickins; Matthew P McCormack
Journal:  Leukemia       Date:  2021-01-22       Impact factor: 11.528

2.  Variations in mRNA and protein levels of Ikaros family members in pediatric T cell acute lymphoblastic leukemia.

Authors:  Julie L Mitchell; Thomas M Yankee
Journal:  Ann Transl Med       Date:  2016-10

3.  A cooperative microRNA-tumor suppressor gene network in acute T-cell lymphoblastic leukemia (T-ALL).

Authors:  Konstantinos J Mavrakis; Joni Van Der Meulen; Andrew L Wolfe; Xiaoping Liu; Evelien Mets; Tom Taghon; Aly A Khan; Manu Setty; Manu Setti; Pieter Rondou; Peter Vandenberghe; Eric Delabesse; Yves Benoit; Nicholas B Socci; Christina S Leslie; Pieter Van Vlierberghe; Frank Speleman; Hans-Guido Wendel
Journal:  Nat Genet       Date:  2011-06-05       Impact factor: 38.330

4.  Regulator of myeloid differentiation and function: The secret life of Ikaros.

Authors:  Olivia L Francis; Jonathon L Payne; Rui-Jun Su; Kimberly J Payne
Journal:  World J Biol Chem       Date:  2011-06-26

5.  Role of Ikaros in T-cell acute lymphoblastic leukemia.

Authors:  Philippe Kastner; Susan Chan
Journal:  World J Biol Chem       Date:  2011-06-26

6.  Convergence of the ZMIZ1 and NOTCH1 pathways at C-MYC in acute T lymphoblastic leukemias.

Authors:  Lesley A Rakowski; Derek D Garagiola; Choi M Li; Margaret Decker; Sarah Caruso; Morgan Jones; Rork Kuick; Tomasz Cierpicki; Ivan Maillard; Mark Y Chiang
Journal:  Cancer Res       Date:  2012-11-16       Impact factor: 12.701

Review 7.  Ikaros and tumor suppression in acute lymphoblastic leukemia.

Authors:  Kimberly J Payne; Sinisa Dovat
Journal:  Crit Rev Oncog       Date:  2011

Review 8.  Mouse models for radiation-induced cancers.

Authors:  Leena Rivina; Michael J Davoren; Robert H Schiestl
Journal:  Mutagenesis       Date:  2016-05-21       Impact factor: 3.000

Review 9.  Global genomic characterization of acute lymphoblastic leukemia.

Authors:  Charles G Mullighan; James R Downing
Journal:  Semin Hematol       Date:  2009-01       Impact factor: 3.851

10.  Ras orchestrates exit from the cell cycle and light-chain recombination during early B cell development.

Authors:  Malay Mandal; Sarah E Powers; Kyoko Ochiai; Katia Georgopoulos; Barbara L Kee; Harinder Singh; Marcus R Clark
Journal:  Nat Immunol       Date:  2009-09-06       Impact factor: 25.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.